(Q34366405)

1 August 2017

1 reference

title

The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective? (English)

1 reference

1 August 2017

0 references

1 reference

Olivry T

1

1 reference

1 August 2017

Marsella R

series ordinal

2

1 reference

1 August 2017

Hillier A

series ordinal

3

1 reference

1 August 2017

publication date

1 September 2001

1 reference

Veterinary Immunology and Immunopathology

1 August 2017

published in

1 reference

1 August 2017

volume

81

1 reference

1 August 2017

issue

3-4

1 reference

1 August 2017

page(s)

347-362

1 reference

Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Combined treatment with concentrated essential fatty acids and prednisolone in the management of canine atopy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Can n-3 polyunsaturated fatty acids be used as immunomodulatory agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Effects of oral sunflower oil and olive oil on serum and cutaneous fatty acid concentrations in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Dietary source of omega-3 fatty acids affects endotoxin-induced peritoneal macrophage tumor necrosis factor and eicosanoid synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Inability of Short-duration Treatment with a 5-Lipoxy-genase Inhibitor to Reduce Clinical Signs of Canine Atopy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Control of endothelial leukocyte adhesion molecules by fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

The effect of essential fatty acid supplementation on keratinocyte replication

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Effects of linoleic acid supplements on atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Effects of sesamin and alpha-tocopherol, individually or in combination, on the polyunsaturated fatty acid metabolism, chemical mediator production, and immunoglobulin levels in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

A blinded, placebo-controlled study of the efficacy of borage seed oil and fish oil in the management of canine atopy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Epogam evening primrose oil treatment in atopic dermatitis and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Systematic review of treatments for atopic eczema.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Essential fatty acid metabolism and its modification in atopic eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Effects of dietary fish oil lipids on allergic and inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Eicosapentaenoic acid-induced changes in membrane fluidity and cell adhesion molecules in cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Reduced levels of prostaglandin precursors in the blood of atopic patients: defective delta-6-desaturase function as a biochemical basis for atopy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Effects of zinc and linoleic acid supplementation on the skin and coat quality of dogs receiving a complete and balanced diet

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

How the glucocorticoids suppress immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Oxidative metabolism of dihomogammalinolenic acid by guinea pig epidermis: evidence of generation of anti-inflammatory products

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Additive benefits of EFAs in dogs with atopic dermatitis after partial response to antihistamine therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Differential regulation of human T lymphocyte protein kinase C activity by unsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Double blind, placebo-controlled, crossover study of evening primrose oil in the treatment of canine atopy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Canine atopic disease: therapeutic use of an evening primrose oil and fish oil combination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Essential fatty acids and the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2427%2801%2900316-6

7 January 2021

10.1016/S0165-2427(01)00316-6

Identifiers

DOI

1 reference

1 August 2017

1 reference